Results 31 to 40 of about 19,614 (168)

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal

Química Nova, 2009
The international organizations CLSI and EUCAST developed reference methodologies for activity evaluation antifungal. The aim of this work was to compare the recommended methodologies by the CLSI and EUCAST in the antifungal activity evaluation of crude ...
Marcos Aurélio Stoppa, Luciana Assirati Casemiro, Adriana Helena Chicharo Vinholis, Wilson Roberto Cunha, Márcio Luis Andrade e Silva, Carlos Henrique Gomes Martins, Niege Araçari Jacometti Cardoso Furtado   +6 more
doaj   +1 more source

Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

Journal of Global Antimicrobial Resistance, 2022
: Objectives: To report reference method antimicrobial susceptibility testing results for recent clinical isolates of Gram-negative bacilli from Morocco.
James A. Karlowsky, Samuel K. Bouchillon, Amina Benaouda, Nabila Soraa, Khalid Zerouali, Naglaa Mohamed, Taha Alami, Daniel F. Sahm   +7 more
doaj   +1 more source

Appraisal of the domestic kit «MICMICRO » for antimicrobial susceptibility testing by serial microdilution method [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2020
Objective. To assess efficiency of the “MIC-MICRO” kit developed in the Department of New Technologies of the Saint-Petersburg Pasteur Institute, on reference strains and clinical bacterial isolates. Materials and Methods. In order to assess the “MIC-
Samoilova A.A., Kraeva L.A., Likhachev I.V., Rogacheva E.V., Verbov V.N., Mikhailov N.V., Zueva E.V.   +6 more
doaj   +1 more source

Implementing the Updated Guidelines in Routine Clinical Microbiology Reporting [Letter]

Infection and Drug Resistance, 2022
Ketaki Niranjan Pathak, Sourav Sen Department of Microbiology, Symbiosis Medical College for Women (SMCW), Symbiosis International (Deemed University) (SIU), Pune, Maharashtra, IndiaCorrespondence: Ketaki Niranjan Pathak, Department of Microbiology ...
Pathak KN, Sen S
doaj  

Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?

BMC Infectious Diseases, 2012
Background In several European Countries, by the end of 2012, CLSI guidelines will be replaced by EUCAST. We compared antimicrobial susceptibility results of a large number of respiratory pathogens using both EUCAST and previously adopted CLSI criteria ...
Marchese Anna, Esposito Susanna, Barbieri Ramona, Bassetti Matteo, Debbia Eugenio   +4 more
doaj   +1 more source

Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures

Microorganisms, 2021
Rapid determination of bacterial antibiotic susceptibility is important for proper treatment of infections. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has recently published guidelines for rapid antimicrobial susceptibility ...
Ohad Shifman, Tamar Aminov, Moshe Aftalion, David Gur, Hila Cohen, Elad Bar-David, Ofer Cohen, Emanuelle Mamroud, Haim Levy, Ronit Aloni-Grinstein, Ida Steinberger-Levy, Shahar Rotem   +11 more
doaj   +1 more source

Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy

Journal of Fungi, 2022
The isolation of a pan-echinocandin-resistant Candida parapsilosis strain (anidulafungin, caspofungin, micafungin and rezafungin EUCAST MICs > 8 mg/L) from urine of a patient following prolonged exposure to echinocandins (38 days of micafungin followed ...
Maria Siopi, Antonios Papadopoulos, Anastasia Spiliopoulou, Fotini Paliogianni, Nissrine Abou-Chakra, Maiken Cavling Arendrup, Christina Damoulari, Georgios Tsioulos, Efthymia Giannitsioti, Frantzeska Frantzeskaki, Iraklis Tsangaris, Spyros Pournaras, Joseph Meletiadis   +12 more
doaj   +1 more source

Antifungal susceptibility testing for yeasts: how, when and why, according to the new EUCAST guidelines

Microbiologia Medica, 2011
Antifungal susceptibility testing of yeasts and the development of interpretive breakpoints are nowadays very important topics both for the increasing incidence of invasive mycoses and number of available antifungal drugs and for the appearance of ...
Esther Manso, Claudio Farina, Stefano Andreoni, Marco Conte, Paolo Fazii, Gianluigi Lombardi, Silvana Sanna   +6 more
doaj   +1 more source

Antifungal susceptibility testing inAspergillusspp. according to EUCAST methodology [PDF]

Medical Mycology, 2006
The availability of new antifungal agents has multiplied the demand for in vitro antifungal susceptibility testing for Aspergillus spp. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has charged its Antifungal Susceptibility Testing Subcommittee (AFST-EUCAST) with the preparation of new guidelines for in vitro susceptibility ...
Lass-Flörl, C., Cuenca-Estrella, M., Denning, D. W., Rodriguez-Tudela, J. L.   +3 more
openaire   +2 more sources

EUCAST Ibrexafungerp MICs and Wild-Type Upper Limits for Contemporary Danish Yeast Isolates

Journal of Fungi, 2022
Ibrexafungerp is a novel triterpenoid antifungal that inhibits glucan synthase and thus fungal cell wall synthesis. We examined the in vitro activity against contemporary clinical yeast, investigated inter-laboratory and intra-laboratory variability ...
Karin M. Jørgensen, Karen M. T. Astvad, Rasmus K. Hare, Maiken C. Arendrup   +3 more
doaj   +1 more source